Karel Smetana

9.7k total citations · 1 hit paper
418 papers, 7.6k citations indexed

About

Karel Smetana is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Karel Smetana has authored 418 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 231 papers in Molecular Biology, 99 papers in Immunology and 63 papers in Oncology. Recurrent topics in Karel Smetana's work include RNA modifications and cancer (71 papers), Galectins and Cancer Biology (51 papers) and Glycosylation and Glycoproteins Research (43 papers). Karel Smetana is often cited by papers focused on RNA modifications and cancer (71 papers), Galectins and Cancer Biology (51 papers) and Glycosylation and Glycoproteins Research (43 papers). Karel Smetana collaborates with scholars based in Czechia, United States and Germany. Karel Smetana's co-authors include Harris Busch, Barbora Dvořánková, Lukáš Lacina, H. Busch, Hans‐Joachim Gabius, Pavol Szabó, Sabine André, Ferenc Györkey, Ondřej Kodet and Jan Motlík and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Applied Physics and Biomaterials.

In The Last Decade

Karel Smetana

412 papers receiving 7.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Role of IL-6 in Cancer Cell Invasiveness and Metastasis—Overview and Therapeutic Opportunities

2022 139 citations Lukáš Lacina, Michal Kolář et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karel Smetana Czechia	41	4.1k	1.5k	1.2k	576	555	418	7.6k
Alex Markham United Kingdom	28	3.8k 0.9×	803 0.5×	1.2k 1.0×	811 1.4×	224 0.4×	58	7.5k
Rolf D. Issels Germany	44	3.2k 0.8×	1.6k 1.0×	1.2k 1.0×	628 1.1×	2.4k 4.3×	165	9.2k
Kim S. Midwood United Kingdom	44	2.1k 0.5×	1.9k 1.3×	825 0.7×	1.1k 1.9×	490 0.9×	86	7.3k
Scott I. Simon United States	60	3.0k 0.7×	3.5k 2.3×	788 0.7×	1.3k 2.3×	1.1k 2.0×	184	10.3k
Jian‐Liang Li United States	47	3.0k 0.7×	571 0.4×	781 0.7×	551 1.0×	447 0.8×	203	7.0k
Yong Gu China	44	5.0k 1.2×	1.8k 1.2×	1.5k 1.3×	825 1.4×	1.4k 2.5×	190	9.5k
Douglas A. Steeber United States	53	2.3k 0.6×	4.1k 2.7×	1.3k 1.1×	313 0.5×	1.4k 2.5×	106	9.9k
Petra Boukamp Germany	50	5.3k 1.3×	1.2k 0.8×	2.2k 1.9×	1.9k 3.3×	485 0.9×	138	11.4k
Jan C. Simon Germany	55	2.6k 0.6×	3.0k 2.0×	987 0.8×	1.9k 3.3×	1.2k 2.1×	205	9.9k
Michael Landthaler Germany	58	2.4k 0.6×	513 0.3×	2.3k 1.9×	857 1.5×	1.5k 2.8×	303	11.1k

Countries citing papers authored by Karel Smetana

Since Specialization

Citations

This map shows the geographic impact of Karel Smetana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karel Smetana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karel Smetana more than expected).

Fields of papers citing papers by Karel Smetana

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karel Smetana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karel Smetana. The network helps show where Karel Smetana may publish in the future.

Co-authorship network of co-authors of Karel Smetana

This figure shows the co-authorship network connecting the top 25 collaborators of Karel Smetana. A scholar is included among the top collaborators of Karel Smetana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karel Smetana. Karel Smetana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dvořánková, Barbora, Lukáš Lacina, Jana Šáchová, et al.. (2023). Unravelling heterogeneous effects of cancer‑associated fibroblasts on poor prognosis markers in breast cancer EM‑G3 cell line: In vitro‑targeted treatment (anti‑IL-6, anti‑VEGF-A, anti‑MFGE8) based on transcriptomic profiling. Oncology Reports. 51(1). 2 indexed citations

Stakheev, Dmitry, Karolína Strnadová, Lukáš Lacina, et al.. (2023). Novel PD-L1- and collagen-expressing patient-derived cell line of undifferentiated pleomorphic sarcoma (JBT19) as a model for cancer immunotherapy. Scientific Reports. 13(1). 19079–19079. 2 indexed citations

Smetana, Karel & Jan Brábek. (2020). Role of Interleukin-6 in Lung Complications in Patients With COVID-19: Therapeutic Implications. In Vivo. 34(3 suppl). 1589–1592. 24 indexed citations

Szabó, Pavol, et al.. (2013). Comparative Analysis of IL-8 and CXCL-1 Production by Normal and Cancer Stromal Fibroblasts. Folia Biologica. 59(3). 134–137. 9 indexed citations

Chovanec, Martin, František Sabol, Sabine André, et al.. (2012). Early Stages of Trachea Healing Process: (Immuno/Lectin) Histochemical Monitoring of Selected Markers and Adhesion/ Growth-Regulatory Endogenous Lectins. Folia Biologica. 58(4). 135–143. 9 indexed citations

Dvořánková, Barbora, Pavol Szabó, Lukáš Lacina, et al.. (2012). Fibroblasts prepared from different types of malignant tumors stimulate expression of luminal marker keratin 8 in the EM-G3 breast cancer cell line. Histochemistry and Cell Biology. 137(5). 679–685. 25 indexed citations

Smetana, Karel, et al.. (2008). The RNA Content of Nucleolar Bodies Is Related to Their Size – a Cytochemical Study on Human Monocytes and Lymphocytes in Blood Smears and Blood Cytospins. Folia Biologica. 54(4). 130–133. 2 indexed citations

Smetana, Karel, et al.. (2008). To the Density and Distribution of Heterochromatin in Differentiating, Maturing and Apoptotic Cells Represented by Granulocytic, Lymphocytic and Erythrocytic Precursors. Folia Biologica. 54(1). 8–11. 1 indexed citations

Lacina, Lukáš, Karel Smetana, Barbora Dvořánková, et al.. (2007). Stromal fibroblasts from basal cell carcinoma affect phenotype of normal keratinocytes. British Journal of Dermatology. 156(5). 819–829. 46 indexed citations

10.

Löhr, Matthias, M. William Lensch, Sabine André, et al.. (2007). Murine Homodimeric Adhesion/Growth-Regulatory Galectins-1, -2 and -7: Comparative Profiling of Gene/ Promoter Sequences by Database Mining, of Expression by RT-PCR/Immunohistochemistry and of Contact Sites for Carbohydrate Ligands by Computational Chemistry. Folia Biologica. 53(4). 109–128. 28 indexed citations

11.

Lacina, Lukáš, et al.. (2006). Immunocyto- and histochemical profiling of nucleostemin expression: Marker of epidermal stem cells?. Journal of Dermatological Science. 44(2). 73–80. 17 indexed citations

12.

Gál, Péter, Tomáš Toporcer, B. Vidinský, et al.. (2006). Early Changes in the Tensile Strength and Morphology of Primary Sutured Skin Wounds in Rats. Folia Biologica. 52(4). 109–115. 34 indexed citations

13.

Smetana, Karel, et al.. (2005). Intranucleolar Translocation of AgNORs in Early Granulocytic Precursors in Chronic Myeloid Leukaemia and K 562 Cells. Folia Biologica. 51(4). 89–92. 7 indexed citations

14.

Smetana, Karel, et al.. (2004). A Note on the Decreased Number and Loss of Fibrillar Centres in Nucleoli of Apoptotic HL-60 Leukaemic Granulocytic Precursors Produced by 5-Aminolaevulinic Acid-Based Photodynamic Treatment. Folia Biologica. 50(1). 15–20. 3 indexed citations

15.

Chovanec, Martin, et al.. (2004). Comparison of the Expression of Langerin and 175 kD Mannose Receptor in Antigen-Presenting Cells in Normal Human Skin and Basal Cell Carcinoma. Folia Biologica. 50(2). 71–73. 4 indexed citations

16.

Smetana, Karel, et al.. (2001). Immunocytochemical localization of nucleophosmin and RH-II/Gu protein in nucleoli of HeLa cells after treatment with actinomycin D. Acta Histochemica. 103(3). 325–334. 8 indexed citations

17.

Smetana, Karel, Jan Plzák, Zuzana Holı́ková, et al.. (2001). Cells of porcine epidermis and corneal epithelium are not recognized by human natural anti-alpha-galactoside IgG.. PubMed. 47(6). 200–5. 3 indexed citations

18.

Holı́ková, Zuzana, Karel Smetana, Jiřina Bartůňková, et al.. (2000). Human Epidermal Langerhans Cells Are Selectively Recognized by Galectin-3 but Not by Galectin-1. Folia Biologica. 46(5). 195–198. 8 indexed citations

19.

Holı́ková, Zuzana, Karel Smetana, M. Burchert, et al.. (1999). Expression of galectin-3, galectin-3-binding epitopes and of Gal/GalNAc-binding sites in keratinocytes of the adult human epidermis. 5(2). 11–20. 3 indexed citations

20.

Smetana, Karel, et al.. (1995). Mapping of endogenous lectins in macrophages colonizing an implanted polymer surface — effect of polymer structure. Biomaterials. 16(15). 1149–1152. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact